The cocktail YFSS, consisting of Y27632, Forskolin, SB431542 and SP600125, which selectively targets the ROCK, cAMP, TGF‐β and JNK signalling pathways, respectively, was found to effectively trigger differentiation in human GBM cells. This evidence concerns the gene MAPK8 and glioblastoma.